0A4N fundamentals
An in-depth look to GENETIC TECHNOLOGIES ADR EACH REPR 30 SPON operating, investing, and financing activities
0A4N free cash flow for H1 24 is -2.56 M USD. For 2023, 0A4N free cash flow was -6.42 M USD and operating cash flow was -6.41 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM